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ABSTRACT
Reporting two cases of mixed adenocarcinoma and neuroendocrine carcinoma of the ovary. A case report two cases of 
an ovarian cyst suspect malignancy after complete surgical staging in woman aged 39 year old and 72 year old. By this 
case report, we want to know prognosis of the malignancy. Mixed adenocarcinoma and neuroendocrine carcinoma of 
the ovary of the first case arised from mature cystic teratoma, and second case as metastatic process from gastrointestinal 
tract. Mixed adenocarcinoma and neuroendocrine carcinoma is rare hystologic type of ovarian cancer. Need further 
exploration to know the survival of this hystologic type. 
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ABSTRAK
Artikel ini melaporkan dua kasus, yaitu mixed adenocarcinoma dan neuroendocrine carcinoma ovarium, dua kasus 
kista ovarium curiga ganas pada pasien berusia 39 tahun dan 72 tahun. Terhadap kedua pasien dilakukan komplit 
surgical staging. Melalui laporan kasus ini, diharapkan bisa diketahui prognosis kasus. Mixed adenocarcinoma dan 
neuroendocrine carcinoma ovarium pada kasus pertama timbul dari teratoma matur kistik, sedangkan kasus kedua 
merupakan penyebaran dari traktus digestivus. Mixed adenocarcinoma dan neuroendocrine carcinoma merupakan tipe 
histologi kanker ovarium yang jarang. Ia membutuhkan eksplorasi lebih lanjut untuk mengetahui survival dari tipe 
histologi ini. 
Kata Kunci: mixed adenocarcinoma dan neuroendocrine carcinoma, ovarium, surgical staging
INTRODUCTION
Approximately 75–80% of epithelial ovarian cancers are serous hystologic type, with the majority being high grade cancers. Less common subtypes are mucinous 
(10%), endometrioid (10%), clear cell, Brenner and undifferentiated carcinomas. 
Each tumor type has a hystologic pattern that recapitulates the epithelial features 
of a section of the lower genital tract. Although epithelial ovarian cancer is often 
thought of as a single entity, the different hystologic types are variable in their 
behavior. Commonly, two or more cell types are mixed. Within each hystologic type, 
tumors are further categorized as benign, borderline (low malignant potential) or 
malignant. Adenocarcinoma is derived from mucinous tumor, that categorized as 
malignant tumor.
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Neuroendocrine tumors consist of a spectrum of 
malignancies that arise from the diffuse neuroendocrine 
cell system. Prognosis is dependent on hystologic 
subtype and site of origin. The family of well 
differentiated neoplasms (i.e. carcinoid and atypical 
carcinoid) is morphologically and clinically distinct 
from high-grade neuroendocrine carcinoma (i.e., 
small cell and large cell). This latter entity is closely 
related to pulmonary small-cell carcinoma, is highly 
aggressive, and is generally managed with a multimodality 
approach including platinum based chemotherapy. 
Well and poorly differentiated neuroendocrine tumors 
are grouped together only because of generic 
neuroendocrine marker expression (i.e. expression 
of the markers synaptophysin and chromogranin 
detected by immunohistochemistry).1 The biology 
and clinical outcome of poorly differentiated 
neuroendocrine carcinomas, however, are vastly 
different from the well differentiated neuroendocrine 
tumors. In recent decades, there has been an 
increased reported incidence of neuroendocrine tumors, 
which may reﬂect improvements in standardized 
classiﬁcation criteria, and increased diagnostic 
recognition. Neuroendocrine tumors primary to the 
gynecologic tract are still considered to be uncommon, 
with limited prospective data from which to guide 
decisions.2 This case report, reported rarely case of 
mixed adenocarcinoma and neuroendocrine carcinoma. 
There were limited data of this case. By this case 
report, we can learn how to manage the patient 
and also prognosis of this malignancy. 
CASE REPORT
First Case
A woman of 39 year old complained about an 
abdominal enlargement and also abdominal discomfort. 
Patient without living child and married for 6 years. 
Gynecological examination of internal genital organ 
and the mass, was difficult to, because of massive 
ascites. Ultrasound examination found hypohyperechoic 
mass with diameter 10.1x4.83 cm, irregular border 
and seen ascites. Tumor markers examination show 
increased of Ca-125 (414.2), Ca 19-9 > 500. The patient 
underwent laparotomy (unilateral salphingooforectomy)-
frozen section. During operation, 2000 cc ascites was 
found and sent for cytologic examination. Cystic 
mass with solid part was found from right adnexa 
with diameter 20x15 cm, irregular surface. Done 
right salpingoophorectomy and frozen section. From 
left adnexa found mixed cystic and solid mass with 
diameter 10x10 cm. Frozen section result was mixed 
germ cell and sex cord stromal tumor, seems mixed 
type of mature teratoma and granulosa cell tumor. 
Cytology result was reactive mesothelial hyperplasia. 
The operation continued with complete surgical staging 
(total abdominal hysterectomy, left salphingoopho-
rectomy, omentectomy, appendisectomy, bilateral 
pelvic lymphadenctomy, paraaortic lymphadenectomy 
and peritoneal biopsy). 
Pathology anatomy result were: mixed adeno 
and neuro endocrine carcinoma (MANEC) arising in 
mature cystic teratoma from both ovaries dd/MANEC 
metastasis from another organ. To ensure tumor 
type of neuroendocrine carcinoma, immunochemistry 
examination (Chromogranin, neurospecific-enolase 
and synaptopisin) was done. Conclusion of immuno-
chemistry was support neoplasm with neuroendocrine 
feature. But these examination can not used to 
enactive tumor biologic behavior.
Figure 1: Frozen section microscopically: tubular structure covered by 
cuboid epithelium (blue arrow), cells with increase of N/C ratio, irregular 
nucleus membrane, hyperchromatic, found mitotic process (red arrow)
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Figure 2: Tumor mass consist of proliferated neoplastic epithel cells, in 
clusters and trabecular pattern infiltrative in the desmoplastic stroma.
This patient plan to receive adjuvant chemotherapy 
which give Gemcitabine Carboplatin regimen for sixth 
series. Carboplatin dose will give based on area under 
curve-5 and Gemcitabine dose will give 1000 mg/m2 
body surface area. Spacing of each chemotherapy 
is every 3 weeks. After each series of chemotherapy, 
will do clinical evaluation and tumor marker 
evaluation to know chemotherapy response. 
Second Case
A woman of 72 year old complained about an 
abdominal enlargement and also abdominal 
discomfort. Patient without living child and married 
for 45 years. Gynecological examination found cystic 
mass with solid part with diameter 30 x 25 cm, clear 
border and mobile. Ultrasound examination found 
hypohyperechoic mass with unmeasured diameter, 
multiloculer and seen no ascites. Tumor markers 
examination show increased of Ca-125 (105.5), Ca 
19-9 > 16.17. The patient underwent laparotomy (right 
salphingooforectomy)-frozen section. During operation 
found minimal ascites and done cytology examination 
of ascites. Found cystic mass with solid part from 
right adnexa with diameter 20x15 cm, irregular 
surface. Done right salpingoophorectomy and frozen 
section. From left adnexa found within normal limit. 
Frozen section result was mucinous carcinoma. Cytology 
result was atypic mesothelial cell. The operation 
continued with complete surgical staging (total 
abdominal hysterectomy, left salphingoophorectomy, 
omentectomy, appendisectomy, bilateral pelvic 
lymphadenctomy, and peritoneal biopsy). 
Pathology Anatomy result were: mixed adeno 
and neuro endocrine carcinoma (MANEC) from left 
ovary and appendix (mucinous adenocarcinoma with 
signet ring cell component and goblet cell carcinoma), 
extent to uterus, suggested arising from appendix. 
And malignant cell metastatic to right and left 
paracolic peritoneum and omentum. To confirm 
primary tumor arising from ovaries or appendix by 
IHK CK 7 and CK 20 examination. To ensure tumor 
type of neuroendocrine carcinoma, immunochemistry 
examination (chromogranin, neurospecific-enolase 
and synaptopisin) was done. Conclusion of immuno-
chemistry examination were neoplasm originated 
from gastrointestinal tract, with neuroendocrine 
dififferentiation. 
Figure 3: Tumor mass consist of proliferated of neoplastic ephitel cells, 
infiltrative in the ovarian stroma (yellow arrow). Corpus albicans (blue arrow)
Figure 4: Neoplastic invasion in omentum with similar pattern
This patient plan to receive adjuvant chemotherapy 
which give Paclitaxel Carboplatin regimen for sixth 
series. Carboplatin dose will give based on area 
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under curve-5 and Paclitaxel dose will give 175 mg/
m2 body surface area. Spacing of each chemotherapy 
is every 3 weeks. After each series of chemotherapy, 
will do clinical evaluation and tumor marker 
evaluation to know chemotherapy response. 
DISCUSSION
Neuroendocrine tumors are neoplasms with a 
broad range of morphologic patterns, grade of 
differentiation and biologic behavior that share 
common features of neuroendocrine programming. 
Neuroendocrine tumors contain various amount of 
molecules involved in regulated release of neuro-
peptide, neurotransmitters and hormones. Most 
neuroendocrine tumors are of endodermal derivation 
and rare entities of rare entities of true neural crest 
origin. They may occur in every topographic location, 
with a predilection of lung, intestine and pancreas. 
Other primary organs include the skin, salivary gland, 
prostate and various sites in the urinary, genital 
and biliary tracts.1,3
Mature cystic teratoma usually was benign 
condition, which consist of three layers of germinal 
cell: ectoderm, mesoderm and endoderm.4,5,6,7 But, 
in rare condition, mature cystic ovary can become 
malignant transformation in one of its component. 
Malignant transformation of mature cystic teratoma 
is a rare condition, happen in 2% from all of ovarian 
malignancy cases. In one of reference, explained 
that neuroendocrine component (mucinous carcinoid 
ovarian tumor) found in mature cystic teratoma of 
1/3 cases.8 This teratoma component support origin 
of ovarian tumor. Primary ovarian tumor is very rare 
and only found in about 0.1% of ovary.9
Neuroendocrine cells have been identified in 
normal epithelium of the female genital tract. 
Ovarian neuroendocrine tumors may develop from 
non neuroendocrine cells in which there has been 
activation of genes that promote neuroendocrine 
differentiation. In the 2000 WHO classification of 
endocrine tumors, such neoplasms were defined as 
mixed exocrine-endocrine tumors when each 
component represents at least 30% of the lesion. 
In the most recent WHO classification of neoplasms 
of the gastrointestinal tract, such neoplasms are 
called “mixed adenoneuroendocrine carcinomas” 
(MANECs). 10,11 
The presence of a neuroendocrine component 
in gastrointestinal adenomas/adenocarcinomas has 
often been reported. Indeed, the systematic application 
of immunohistochemical techniques to the study of 
gastrointestinal tumors has demonstrated that 
neuroendocrine cells occur rather frequently in non-
endocrine neoplasms. Similarly, the presence of an 
exocrine component in gastrointestinal neuroendocrine 
neoplasms, especially in high grade neuroendocrine 
carcinomas, has also been widely documented. There 
is a wide spectrum of such combinations of exocrine 
and neuroendocrine components, ranging from 
adenomas or carcinomas with interspersed neuro-
endocrine cells on the one end to classical neuro-
endocrine tumors with a focal exocrine component 
on the other end. In addition, both the exocrine and 
the neuroendocrine components can have different 
morphological features ranging from adenomas to 
adenocarcinomas with different degrees of 
differentiation in exocrine components and from well 
differentiated to poorly differentiated neuroendocrine 
tumors in neuroendocrine components. However, 
although this spectrum of combinations is frequently 
observed in routine practice, mixed exocrine-
neuroendocrine tumors are rarely found. By definition, 
such neoplasms are those in which each component 
represents at least 30% of the lesion. 10,11 
Mixed adenoneuroendocrine carcinomas (MANECs) 
are morphologically recognizable as both gland 
forming epithelial and neuroendocrine neoplasms 
and they are defined as carcinomas since both 
components are hystologically malignant. An exocrine 
component of squamous cell carcinoma, although 
very rare, can also be observed, especially in 
esophageal and anal tumors. It is worth noting that 
adenocarcinomas with scattered neuroendocrine cells, 
shown by immunohistochemistry, cannot be 
categorized as MANECs, nor can neuroendocrine 
neoplasms with a focal non-neuroendocrine component. 
Although goblet cell carcinoids of the appendix 
have been traditionally considered as mixed exocrine-
neuroendocrine neoplasms, in the 2010 WHO 
classification of tumors of the digestive system they 
have been described in both adenocarcinoma and 
neuroendocrine tumor sections, giving rise to some 
confusion. Appendiceal tubular carcinoids, although 
able to produce mucins focally, are classified among 
neuroendocrine neoplasms in the 2010 WHO 
classification and for this reason we do not include 
them in the present paper. However, it is worth 
noting that these particular appendiceal neoplasms 
require further investigation to better clarify their 
histogenesis, molecular profile and, consequently, 
classification. In some MANECs the neuroendocrine 
and exocrine components occur in separate areas 
of the same lesion (composite or collision neoplasms), 
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while in other MANECs they are intimately and 
diffusely admixed (combined neoplasms). The clinical 
significance and the influence on survival of focal 
neuroendocrine differentiation in gut adenocarcinomas 
still remain controversial. MANECs may constitute 
a diagnostic challenge because frequently only one 
component of the neoplasm is identified. This 
leads to an incomplete diagnosis and suboptimal 
treatment.10,11
In the first case difficult to certain origin of the 
primary tumor, because from appendix found 
neuroendocrine tumor which can metastatic to 
ovaries. And in the other side, in the ovary found 
neuroendocrine component in teratoma which 
metastatic to appendix, contralateral ovary, vaginal 
cuff, cervix, uterus, omentum, paraaortic lymph node 
and douglas cavity. 
First patient in this case report received adjuvant 
chemotherapy which give Gemcitabine Carboplatin 
for sixth series. After sixth series of chemotherapy, 
there were no clinical sign of new mass and tumor 
markers in the normal range. Mixed adeno and 
neuroendocrine carcinoma of the ovary is very rare 
case. By limited data or case report of MANECs of 
the ovary, prognosis of this case still observed. Second 
patient refused to receive adjuvant chemotherapy.
CONCLUSION
Neuroendocrine tumors of the gynecologic tract 
comprise a spectrum of entities of variable biologic 
potential. Although rare, accurate diagnosis of such 
entities is important for both therapeutic and 
prognostic purposes. 
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